Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge acts for Orexo in connection with its rights offering
Mandate

Vinge acts for Orexo in connection with its rights offering

May 05, 2011

Orexo AB (publ) (NASDAQ OMX Stockholm) has announced an underwritten rights offering with pre-emptive rights for the shareholders and holders of the company’s convertible bonds.

Vinge acts for Orexo. The Vinge team is headed by capital markets partner Erik Sjöman and includes Christian Lindhé, Jakob Warren and Markus Larsson. Dain Nevonen and Maria Doeser are also on the Vinge team.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025